Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wade Berrettini

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|March 11, 2003
Elucidating the role of genetic factors in smoking behavior and nicotine dependenceCaryn Lerman, Wade Berrettini
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2005
Treating tobacco dependence: state of the science and new directionsCaryn Lerman, Freda Patterson, Wade Berrettini
Molecular Pharmacology|October 1, 2010
Acetylcholine receptor (AChR) α5 subunit variant associated with risk for nicotine dependence and lung cancer reduces (α4β2)₂α5 AChR functionAlexander Kuryatov, Wade Berrettini, Jon Lindstrom
Child and Adolescent Psychiatry and Mental Health|July 5, 2008
ADHD characteristics: I. Concurrent co-morbidity patterns in children & adolescentsJosephine Elia, Paul Ambrosini, Wade Berrettini
Nature Reviews. Neuroscience|October 21, 2011
Pharmacogenetic approaches to the treatment of alcohol addictionMarkus Heilig, David Goldman, Wade Berrettini, et al.
Brain Research|September 4, 2010
Ultrastructural relationship between the mu opioid receptor and its interacting protein, GPR177, in striatal neuronsArith-Ruth S Reyes, Robert Levenson, Wade Berrettini, et al.
Biological Psychiatry|January 16, 2007
Diplotypes of the human serotonin 1B receptor promoter predict growth hormone responses to sumatriptan in abstinent alcohol-dependent menHoward B Moss, Thomas L Hardie, John P Dahl, et al.
SSM. Mental Health|February 13, 2023
Application of the COM-B model to patient barriers and facilitators of retention in medication treatment for opioid use disorder in rural Northeastern United States: A qualitative studyMelissa N Poulsen, Patrick B Asdell, Wade Berrettini, et al.
Journal of Affective Disorders|October 18, 2015
Risk factors for suicide in bipolar I disorder in two prospectively studied cohortsWilliam Coryell, Abby Kriener, Brandon Butcher, et al.
Journal of Substance Use and Addiction Treatment|December 10, 2023
Clinical stakeholders' perceptions of patient engagement in outpatient medication treatment for opioid use disorder: A qualitative studyMelissa N Poulsen, Sophie A Roe, Patrick B Asdell, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|March 11, 2003
Elucidating the role of genetic factors in smoking behavior and nicotine dependenceCaryn Lerman, Wade Berrettini
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2005
Treating tobacco dependence: state of the science and new directionsCaryn Lerman, Freda Patterson, Wade Berrettini
Molecular Pharmacology|October 1, 2010
Acetylcholine receptor (AChR) α5 subunit variant associated with risk for nicotine dependence and lung cancer reduces (α4β2)₂α5 AChR functionAlexander Kuryatov, Wade Berrettini, Jon Lindstrom
Child and Adolescent Psychiatry and Mental Health|July 5, 2008
ADHD characteristics: I. Concurrent co-morbidity patterns in children & adolescentsJosephine Elia, Paul Ambrosini, Wade Berrettini
Nature Reviews. Neuroscience|October 21, 2011
Pharmacogenetic approaches to the treatment of alcohol addictionMarkus Heilig, David Goldman, Wade Berrettini, et al.
Brain Research|September 4, 2010
Ultrastructural relationship between the mu opioid receptor and its interacting protein, GPR177, in striatal neuronsArith-Ruth S Reyes, Robert Levenson, Wade Berrettini, et al.
Biological Psychiatry|January 16, 2007
Diplotypes of the human serotonin 1B receptor promoter predict growth hormone responses to sumatriptan in abstinent alcohol-dependent menHoward B Moss, Thomas L Hardie, John P Dahl, et al.
SSM. Mental Health|February 13, 2023
Application of the COM-B model to patient barriers and facilitators of retention in medication treatment for opioid use disorder in rural Northeastern United States: A qualitative studyMelissa N Poulsen, Patrick B Asdell, Wade Berrettini, et al.
Journal of Affective Disorders|October 18, 2015
Risk factors for suicide in bipolar I disorder in two prospectively studied cohortsWilliam Coryell, Abby Kriener, Brandon Butcher, et al.
Journal of Substance Use and Addiction Treatment|December 10, 2023
Clinical stakeholders' perceptions of patient engagement in outpatient medication treatment for opioid use disorder: A qualitative studyMelissa N Poulsen, Sophie A Roe, Patrick B Asdell, et al.
Pageof 6